Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519263 | SCV000618901 | uncertain significance | not provided | 2017-07-11 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the RYR1 gene. The S3235R variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The S3235R variant is observed in 1/16502 (0.01%) alleles from individuals of South Asian background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The S3235R variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved in mammals. However, in silico analysis predicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV000795671 | SCV000935141 | uncertain significance | RYR1-related disorder | 2024-02-01 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 3235 of the RYR1 protein (p.Ser3235Arg). This variant is present in population databases (rs747488155, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 450330). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RYR1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV001262656 | SCV001440602 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV002289709 | SCV002580764 | uncertain significance | Central core myopathy | 2022-03-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002525168 | SCV003576691 | uncertain significance | Inborn genetic diseases | 2021-09-27 | criteria provided, single submitter | clinical testing | The c.9703A>C (p.S3235R) alteration is located in exon 66 (coding exon 66) of the RYR1 gene. This alteration results from a A to C substitution at nucleotide position 9703, causing the serine (S) at amino acid position 3235 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |